Eupraxia Pharmaceuticals Inc. (EPRXF) Stock Analysis
DELISTED
What happened to Eupraxia Pharmaceuticals Inc. (EPRXF) stock?
Eupraxia Pharmaceuticals Inc. (EPRXF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $108M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Eupraxia Pharmaceuticals Inc. (EPRXF). Eupraxia Pharmaceuticals Inc. is a clinical-stage biotechnology company developing innovative therapies, with its lead compound EP-104IAR in Phase II trials for knee osteoarthritis and animal osteoarthritis.
Last analyzed: Jun 14, 2026Dated analysis: the newest financial statements on file are 31 months old (Mar 1, 2024), so the figures and score below describe that period, not today.
Eupraxia Pharmaceuticals Inc. (EPRXF) Healthcare & Pipeline Overview
EPRXF OTC Market Information
EPRXF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy EPRXF shares?
No. EPRXF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for EPRXF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before EPRXF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Eupraxia Pharmaceuticals Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.